Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Myovant Sciences Ltd. | 1,043,824 | reported | 03 Apr 2020 | tx 6+2,043,573 |
| Lyell Immunopharma, Inc. | 74,266 | reported | 11 Feb 2026 | tx 19+17,686,250−7,516,359 |
| MEDIVATION, INC. | 31,000 | reported | 17 Feb 2015 | tx 167+1,331,452−1,460,587 |
| Blueprint Medicines Corp | 0 | reported | 17 Jul 2025 | tx 31+98,649−98,649 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2026 | SALE | Lyell Immunopharma, Inc. | 7,455 | 23.39 USD | |
| 09 Feb 2026 | GRANT_AWARD | Lyell Immunopharma, Inc. | 20,000 | 0.00 USD | |
| 10 Feb 2026 | SALE | Lyell Immunopharma, Inc. | 438 | 23.12 USD | |
| 10 Feb 2026 | GRANT_AWARD | Lyell Immunopharma, Inc. | 155,000 | 0.00 USD | deriv |
| 10 Nov 2025 | SALE | Lyell Immunopharma, Inc. | 412 | 16.11 USD | |
| 27 Oct 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 175,000 | 0.00 USD | deriv |
| 20 Aug 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 40,000 | 0.00 USD | |
| 21 Aug 2025 | SALE | Lyell Immunopharma, Inc. | 7,257 | 10.54 USD | |
| 12 Aug 2025 | SALE | Lyell Immunopharma, Inc. | 406 | 10.34 USD | anomaly |
| 11 Aug 2025 | SALE | Lyell Immunopharma, Inc. | 391 | 10.53 USD | anomaly |
| 17 Jul 2025 | TENDER | Blueprint Medicines Corp | 13,254 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 3,902 | — | |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 10,909 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,300 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 5,300 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 21,818 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 10,909 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,570 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 7,500 | — | deriv |
| 17 Jul 2025 | OTHER | Blueprint Medicines Corp | 4,875 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | Blueprint Medicines Corp | 3,902 | 128.12 USD | |
| 14 Mar 2025 | PURCHASE | Lyell Immunopharma, Inc. | 175,000 | 0.61 USD | |
| 10 Feb 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 337,500 | 0.00 USD |